Erythropoietin and transfusions among critically ill patients

JAMA. 2003 Mar 26;289(12):1511; author reply 1512. doi: 10.1001/jama.289.12.1511-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anemia / prevention & control*
  • Critical Illness*
  • Erythrocyte Transfusion* / economics
  • Erythropoietin / adverse effects
  • Erythropoietin / economics
  • Erythropoietin / therapeutic use*
  • Hemoglobins / metabolism
  • Humans
  • Recombinant Proteins
  • Red-Cell Aplasia, Pure

Substances

  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin